DV
Dividend Vision

VCEL — Vericel Corporation

Vericel Corporation (VCEL)

Total return is -96.1% over the past 29.5 years, 1624.1 points behind SPY at 1528.0%. Its deepest 1-year drawdown was 31.0%.

VCEL is an equity stock rather than an ETF—it is a single company security that trades as a stock. As a biotechnology and regenerative medicine company, it does not function as a diversified fund with an underlying basket of assets. The company does not currently pay dividends, making it unsuitable for income-focused investors seeking regular distributions. This security appeals primarily to growth-oriented investors interested in exposure to the regenerative medicine and cellular therapy sector.

VCEL key facts

Asset type
Stock
Asset class
Equity
Inception date
02/04/1997
Distribution frequency
None
Last close
$44.20
Market cap
$2,263,332,352
Average volume
276100.0
Beta
1.068
Payout ratio
0.0
P/E ratio
92.0833
Forward P/E
93.4579
EPS
$0.48